Breaking News Instant updates and real-time market news.

CPRX

Catalyst Pharmaceuticals

$3.53

-0.04 (-1.12%)

11:28
06/12/19
06/12
11:28
06/12/19
11:28

Catalyst accuses FDA of 'playing favorites' in lawsuit, says Piper Jaffray

Piper Jaffray analyst Joseph Catanzaro maintained an Overweight rating and $7.50 price target on Catalyst Pharmaceuticals after the company filed a lawsuit against the FDA in relation to the approval of Jacobus' Ruzurgi for the treatment of pediatric LEMS. In a research note to investors, Catanzaro says the suit calls out Ruzurgi's labeling, specifically highlighting that all efficacy data supporting the drug's pediatric approval appears to have been generated in adult patients, and accuses the FDA of "playing favorites" because of pricing considerations. The analyst tells investors that he thinks establishing a precedent that finds Ruzurgi's approval acceptable could nullify many of the incentives in the orphan drug act to develop drugs for orphan indications with unmet need.

CPRX Catalyst Pharmaceuticals
$3.53

-0.04 (-1.12%)

03/19/19
HCWC
03/19/19
NO CHANGE
HCWC
Catalyst's initial launch of Firdapse 'strong,' says H.C. Wainwright
H.C. Wainwright analyst Andrew Fein reiterated a Buy rating and $9 price target on Catalyst Pharmaceuticals, saying the initial look at the Firdapse commercial launch suggests "healthy momentum" and "strong execution" on the part of the company. The analyst also noted that Firdapse is also being investigated in two Phase 3 trials for the treatment of anti-MuSK antibody positive myasthenia gravis and congenital myasthenic syndromes, with both trials planned to read out in the second half of 2019.
05/06/19
PIPR
05/06/19
NO CHANGE
Target $7.5
PIPR
Overweight
Ruzurgi approval to pressure Catalyst Pharmaceuticals, says Piper Jaffray
Piper Jaffray analyst Joseph Catanzaro kept his Overweight rating and $7.50 price target on Catalyst Pharmaceuticals but warned that the stock could come under pressure after the FDA's "unexpected" approval of Jacobus' amifampridine, or Ruzurgi, for the treatment of pediatric LEMS patients. Shares of Catalyst Pharmaceuticals were down over 41% after hours, and the analyst expressed uncertainty over whether the company's Firdapse would be able to maintain the orphan drug price point set at launch. Catanzaro expects the management of Catalyst Pharmaceuticals to comment on the development.
05/07/19
CANT
05/07/19
NO CHANGE
Target $10
CANT
Overweight
Jacobus approval should not impact Catalyst's Firdapse, says Cantor Fitzgerald
The FDA last night approved private company Jacobus' Ruzurgi for the treatment of Lambert-Eaton myasthenic syndrome in patients six to less than 17 years of age, Cantor Fitzgerald analyst Charles Duncan tells investors in a research note. This is the first drug approved for pediatric LEMS, the analyst points out. Catalyst Pharmaceuticals' slightly different salt form of amifampridine, marketed as Firdapse, was the first drug approved for LEMS, but for adults only, he notes. The analyst does not see the approval of Ruzurgi as having a large impact in Firdapse's market potential. He estimates that the pediatric population consists of less than 5% of the prevalent LEMS population. Duncan reiterates an Overweight rating on Catalyst shares with a $10 price target.
05/13/19
PIPR
05/13/19
NO CHANGE
Target $7.5
PIPR
Overweight
Piper says Catalyst's 'impressive' Firdapse sales clouded by Jacobus uncertainty
Piper Jaffray analyst Joseph Catanzaro raised his 2019 Firdapse estimates after the "impressive" results reported by Catalyst Pharmaceuticals in the first quarter of sales for the drug, but he also noted that the recent unexpected approval of Jacobus' Ruzurgi for the treatment of pediatric patients with LEMS puts his Firdapse estimates at risk. While acknowledging the potential implications of a Ruzurgi launch, the analyst raised his FY19 Firdapse sales estimate to $72.5M from $41.0M. Catalyst management said they expects Firdapse revenue to "substantially increase" in Q2 over Q1, but would not give 2019 guidance due to last week's news about Ruzurgi, noted Catanzaro, who keeps an Overweight rating and $7.50 price target on Catalyst shares.

TODAY'S FREE FLY STORIES

FSUGY

Fortescue Metals

$0.00

(0.00%)

22:07
06/26/19
06/26
22:07
06/26/19
22:07
Downgrade
Fortescue Metals rating change at Vertical Group »

Fortescue Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCDA

Tricida

$35.08

-0.07 (-0.20%)

22:01
06/26/19
06/26
22:01
06/26/19
22:01
Initiation
Tricida initiated at Goldman Sachs »

Tricida initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jul

CTL

CenturyLink

$10.91

0.16 (1.49%)

20:54
06/26/19
06/26
20:54
06/26/19
20:54
Upgrade
CenturyLink rating change at Wells Fargo »

CenturyLink upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORF

Morphic Holdings

$0.00

(0.00%)

20:54
06/26/19
06/26
20:54
06/26/19
20:54
Syndicate
Morphic Holdings 6M share IPO priced at $15.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

, MKC

McCormick

$150.58

-2.545 (-1.66%)

20:25
06/26/19
06/26
20:25
06/26/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

WBA

Walgreens Boots Alliance

$52.40

-0.59 (-1.11%)

MKC

McCormick

$150.58

-2.545 (-1.66%)

CAG

Conagra Brands

$28.94

0.035 (0.12%)

PDCO

Patterson Companies

$24.90

0.7 (2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

  • 27

    Jun

ADPT

Adaptive Biotechnologies

$0.00

(0.00%)

20:17
06/26/19
06/26
20:17
06/26/19
20:17
Syndicate
Adaptive Biotechnologies 15M share IPO priced at $20.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

BBIO

BridgeBio

$0.00

(0.00%)

20:15
06/26/19
06/26
20:15
06/26/19
20:15
Syndicate
BridgeBio 20.5M share IPO priced at $17.00 »

The deal priced above the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 27

    Jun

CHNG

Change Healthcare

$0.00

(0.00%)

20:14
06/26/19
06/26
20:14
06/26/19
20:14
Syndicate
Change Healthcare 42.9M share IPO priced at $13.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 09

    Sep

  • 27

    Jun

INXN

Interxion

$73.09

-1.97 (-2.62%)

20:11
06/26/19
06/26
20:11
06/26/19
20:11
Syndicate
Interxion 4M share Secondary priced at $72.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

LECO

Lincoln Electric

$80.24

0.1 (0.12%)

20:09
06/26/19
06/26
20:09
06/26/19
20:09
Downgrade
Lincoln Electric rating change at KeyBanc »

Lincoln Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$42.11

-0.64 (-1.50%)

, CMCSK

Comcast

$0.00

(0.00%)

18:55
06/26/19
06/26
18:55
06/26/19
18:55
Periodicals
MSNBC charging markup for ads in first two Dem debates, WSJ says »

Advertisers were asked to…

CMCSA

Comcast

$42.11

-0.64 (-1.50%)

CMCSK

Comcast

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

MLHR

Herman Miller

$37.86

0.75 (2.02%)

, KBH

KB Home

$23.58

-0.24 (-1.01%)

18:51
06/26/19
06/26
18:51
06/26/19
18:51
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: Herman…

MLHR

Herman Miller

$37.86

0.75 (2.02%)

KBH

KB Home

$23.58

-0.24 (-1.01%)

PECK

Peck

$6.50

0.18 (2.85%)

VRCA

Verrica Pharmaceuticals

$9.44

-0.1 (-1.05%)

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

RAD

Rite Aid

$7.11

0.26 (3.80%)

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

BA

Boeing

$375.05

5.68 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 26

    Jun

  • 27

    Jun

  • 09

    Jul

  • 17

    Jul

  • 24

    Jul

  • 01

    Oct

  • 02

    Oct

OXY

Occidental Petroleum

$50.42

1.05 (2.13%)

, APC

Anadarko

$70.50

0.41 (0.58%)

18:16
06/26/19
06/26
18:16
06/26/19
18:16
Hot Stocks
Icahn says it is 'important' to add new directors to Occidental's board »

Activist investor Carl…

OXY

Occidental Petroleum

$50.42

1.05 (2.13%)

APC

Anadarko

$70.50

0.41 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

PIR

Pier 1 Imports

$8.80

0.14 (1.62%)

18:15
06/26/19
06/26
18:15
06/26/19
18:15
Hot Stocks
Breaking Hot Stocks news story on Pier 1 Imports »

Pier 1 Imports down 18%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

FB

Facebook

$187.60

-1.27 (-0.67%)

, AMZN

Amazon.com

$1,897.51

18.25 (0.97%)

18:08
06/26/19
06/26
18:08
06/26/19
18:08
Periodicals
Facebook in talks to lease office space in Hudson Yards, WSJ reports »

Facebook (FB) is in…

FB

Facebook

$187.60

-1.27 (-0.67%)

AMZN

Amazon.com

$1,897.51

18.25 (0.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

  • 16

    Jul

NOMD

Nomad Foods

$20.34

-0.24 (-1.17%)

18:05
06/26/19
06/26
18:05
06/26/19
18:05
Initiation
Nomad Foods initiated at Goldman Sachs »

Nomad Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.35

0.23 (0.99%)

18:04
06/26/19
06/26
18:04
06/26/19
18:04
Hot Stocks
Investar Holding increases quarterly dividend 5% to 5.5c per share »

Investar Holding declared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ISTR

Investar Holding

$23.35

0.23 (0.99%)

18:02
06/26/19
06/26
18:02
06/26/19
18:02
Hot Stocks
Investar Holding authorizes additional 300,000 share repurchase »

Investar Holding has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$178.77

1.12 (0.63%)

18:00
06/26/19
06/26
18:00
06/26/19
18:00
Hot Stocks
General Dynamics awarded $217M Air Force Intelligence System Support contract »

General Dynamics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TM

Toyota

$123.23

-0.68 (-0.55%)

, SFTBF

SoftBank

$0.00

(0.00%)

17:50
06/26/19
06/26
17:50
06/26/19
17:50
Periodicals
5 Japanese car makers to invest in Toyota-SoftBank self-driving JV, NAR says »

Five more Japanese car…

TM

Toyota

$123.23

-0.68 (-0.55%)

SFTBF

SoftBank

$0.00

(0.00%)

MZDAF

Mazda

$0.00

(0.00%)

SZKMF

Suzuki

$0.00

(0.00%)

FUJHY

Subaru

$0.00

(0.00%)

ISUZY

Isuzu Motors

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$85.32

0.27 (0.32%)

, BA

Boeing

$375.05

5.68 (1.54%)

17:47
06/26/19
06/26
17:47
06/26/19
17:47
Periodicals
United takes 737 MAX off flying schedule until September 3, Reuters says »

United Airlines (UAL) has…

UAL

United Continental

$85.32

0.27 (0.32%)

BA

Boeing

$375.05

5.68 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 24

    Jul

NOMD

Nomad Foods

$20.34

-0.24 (-1.17%)

17:43
06/26/19
06/26
17:43
06/26/19
17:43
Initiation
Nomad Foods initiated at Goldman Sachs »

Nomad Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

, HMNY

Helios and Matheson

$0.00

(0.00%)

17:43
06/26/19
06/26
17:43
06/26/19
17:43
Hot Stocks
AMC Entertainment subscription program A-List surpasses 860K members »

AMC Theatres (AMC) said…

AMC

AMC Entertainment

$9.45

-0.03 (-0.32%)

HMNY

Helios and Matheson

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SECCF

Serco Group

$0.00

(0.00%)

, BAESY

BAE Systems

$0.00

(0.00%)

17:41
06/26/19
06/26
17:41
06/26/19
17:41
Hot Stocks
Serco Group, BAE Systems awarded not exceed $747.1M combined Navy contracts »

BAE Systems (BAESY) and…

SECCF

Serco Group

$0.00

(0.00%)

BAESY

BAE Systems

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRS

Aclaris Therapeutics

$4.45

0.06 (1.37%)

17:28
06/26/19
06/26
17:28
06/26/19
17:28
Hot Stocks
Aclaris Therapeutics plunges 33% after Phase 2 results miss endpoints »

After the close of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.